- Home
- OABI vs DENN Comparison
OABI vs DENN Comparison
Compare OABI & DENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- DENN
- Stock Information
- Founded
- OABI 2012
- DENN 1953
- Country
- OABI United States
- DENN United States
- Employees
- OABI N/A
- DENN N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- DENN Restaurants
- Sector
- OABI Health Care
- DENN Consumer Discretionary
- Exchange
- OABI Nasdaq
- DENN Nasdaq
- Market Cap
- OABI 228.9M
- DENN 237.4M
- IPO Year
- OABI N/A
- DENN 1989
- Fundamental
- Price
- OABI $1.64
- DENN $5.26
- Analyst Decision
- OABI Strong Buy
- DENN
- Analyst Count
- OABI 3
- DENN 0
- Target Price
- OABI $6.67
- DENN N/A
- AVG Volume (30 Days)
- OABI 435.2K
- DENN 831.4K
- Earning Date
- OABI 11-11-2025
- DENN 10-21-2025
- Dividend Yield
- OABI N/A
- DENN N/A
- EPS Growth
- OABI N/A
- DENN N/A
- EPS
- OABI N/A
- DENN 0.30
- Revenue
- OABI $23,027,000.00
- DENN $455,727,000.00
- Revenue This Year
- OABI N/A
- DENN $7.57
- Revenue Next Year
- OABI $44.99
- DENN $1.89
- P/E Ratio
- OABI N/A
- DENN $17.44
- Revenue Growth
- OABI 6.05
- DENN 0.06
- 52 Week Low
- OABI $1.22
- DENN $2.85
- 52 Week High
- OABI $4.87
- DENN $7.73
- Technical
- Relative Strength Index (RSI)
- OABI 45.25
- DENN 63.75
- Support Level
- OABI $1.54
- DENN $5.14
- Resistance Level
- OABI $1.68
- DENN $5.75
- Average True Range (ATR)
- OABI 0.08
- DENN 0.33
- MACD
- OABI 0.01
- DENN 0.05
- Stochastic Oscillator
- OABI 62.79
- DENN 65.63
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About DENN Denny's Corporation
Denny's Corp is America's franchised full-service restaurant chains based on the number of restaurants. The company owns and operates the Denny's brand and the Keke's Breakfast Cafe brand. It provides Pancakes, Appetizers & Soups, Sandwiches & Salads, Breakfast Melts, Omelets, and others. The company generates its revenue from two sources: the sale of food and beverages and the collection of royalties, advertising revenue, initial and other fees, including occupancy revenue, from restaurants operated by their franchisees. Geographically operates in USA states as well as globally like Canada, Mexico, Guatemala, Indonesia, United Kingdom, New Zealand and others. Maximum revenue is from USA and Canada.